Ticker Sage

Company file · VTR

Ventas

United Kingdom was Ventas' fastest-growing region in FY2025, up 131.7%

Revenue rose 18.5% to $5.8B in FY2025, from $4.9B in FY2024. Net income rose 196.0% to $262M. United States was the largest region, at 89% of revenue.

Key facts

Ventas (NYSE: VTR) reported revenue of $5.8B for fiscal 2025, the year ended Dec 31, 2025, up 18.5% from fiscal 2024. Net income was $262M, up 196.0%. In its latest 10-Q, for the quarter ended Sep 30, 2026, revenue was $1.8B, up 23.0% from the same quarter a year earlier, and net income was $67M. The largest piece by region was United States, at 89% of fiscal 2025 revenue. Sources: 10-K for fiscal 2025 (filed Feb 6, 2026) and 10-Q for the quarter ended Sep 30, 2026 (filed Oct 28, 2026).

Revenue$5.8BFY2025 · +18.5% vs FY2024
Net income$262MFY2025 · +196.0% vs FY2024
Operating cash flow$1.6BFY2025 · +23.8% vs FY2024
Cash & equivalents$202Mat Sep 30, 2026 · −72.7% vs FY2025 end
Total debt$13.0BFY2025 end · −3.8% vs FY2024
Diluted shares463MFY2025 avg · +11.1% vs FY2024
Revenue and net income, three fiscal yearsBy fiscal year, $bn
RevenueNet income
Revenue and net income by fiscal yearRevenue FY2023: $4.5B4.5Net income FY2023: −$30M−0.03FY2023Revenue FY2024: $4.9B4.9Net income FY2024: $88M0.09FY2024Revenue FY2025: $5.8B5.8Net income FY2025: $262M0.26FY2025Data: Ticker Sage, from SEC EDGAR · tickersage.com

Source: 10-K FY2025, filed Feb 6, 2026

Quarterly revenue: fiscal 2026 vs a year earlierFiscal Q1–Q3, $bn (each quarter from that quarter's 10-Q)
FY2025FY2026
Quarterly revenue, fiscal 2026 vs 2025FY2025 Q1: $1.4B1.4FY2026 Q1: $1.7B1.7Q1FY2025 Q2: $1.4B1.4FY2026 Q2: $1.7B1.7Q2FY2025 Q3: $1.5B1.5FY2026 Q3: $1.8B1.8Q3Data: Ticker Sage, from SEC EDGAR · tickersage.com

Source: 10-Q filed Apr 28, 2026 · 10-Q filed Jul 30, 2026 · 10-Q filed Oct 28, 2026

How it makes money

FY2025 total by categoryUnited States: $5.2B (89%)Canada: $553M (9%)United Kingdom: $71M (1%)$5.8BFY2025 totalData: Ticker Sage, from SEC EDGARtickersage.com

By region, FY2025

  • LineAmountSharevs FY2024
  • United States$5.2B89%+19.3%
  • Canada$553M9%+5.0%
  • United Kingdom$71M1%+131.7%

Source: 10-K FY2025, XBRL breakdown

By region in FY2025: United States (89%), Canada (9%) and United Kingdom (1%), as shares of total revenue. Total revenue was $5.8B.

By region: three-year mixShare of the total each fiscal year
United StatesCanadaUnited Kingdom

Source: 10-K FY2025

By segment, FY2025

Senior Living Operations$4.3B73%+26.8%
Outpatient Medical and Research Portfolio$898M15%+2.3%
Triple Net Leased Properties$602M10%−3.3%

Share is of FY2025 revenue; the items listed don't cover all of it. The last column is the change from FY2024.

Learn more: Revenue vs. net income · Gross, operating and net margin

What changed last quarter

How the quarter compared with a year earlier

Comparing Q3 2026 (Jul to Sep 2026) compared with Q3 2025 (Jul to Sep 2025)

Each pair of bars shows the dollar amount for both quarters. Longer bar, more money. Bars in a group share one scale.

Q3 2026Q3 2025

Company

Revenue
$1.8B Q3 2026
$1.5B Q3 2025
23.0% increase
Net income
$67M Q3 2026
$69M Q3 2025
2.1% decrease

Source: Ventas 10-Q for the quarter ended Sep 30, 2026, filed Oct 28, 2026

  • Cash & equivalents $202M at Sep 30, 2026, vs $741M at FY2025 end.
  • Operating cash flow, first 9 months of fiscal 2026: $1.4B vs $1.2B a year earlier.

The bull case and the bear case

The bull case

  • Revenue rose 18.5% in FY2025 to $5.8B, from $4.9B a year earlier. 10-K, FY2025
  • Net income rose 196.0% in FY2025 to $262M, from $88M. 10-K, FY2025
  • Operating cash flow rose 23.8% in FY2025 to $1.6B. 10-K, FY2025
  • Total debt fell 3.8% in FY2025 to $13.0B. 10-K, FY2025

The bear case

  • Diluted shares rose 11.1% in FY2025, which spreads profit across more shares. 10-K, FY2025
  • Net income in the quarter ended Sep 30, 2026 was $67M, down 2.1% on a year earlier. 10-Q, quarter ended Sep 30, 2026
  • Triple Net Leased Properties revenue fell 3.3% in FY2025 to $602M. 10-K, FY2025

What optimists and skeptics tend to point to, each tied to a filing. Ticker Sage doesn't pick a side, and neither list is a reason to buy or sell.

What the company does

Ventas is in the health care REITs industry, part of the real estate sector. The SEC files it under Real Estate Investment Trusts.

Ventas reports 3 segments: Senior Living Operations, Outpatient Medical and Research Portfolio and Triple Net Leased Properties.

Its fiscal year ends in December; the latest, FY2025, ended Dec 31, 2025.

Source: 10-K, Item 1 Business

Risks common in this industry

These are general risks for companies in the health care REITs industry. They are not a summary of Ventas’s own risk factors; for those, read Item 1A of its latest 10-K, linked below.

  1. Interest ratesHigher rates raise borrowing costs and can lower property values.
  2. Occupancy and rentsVacancies, tenant defaults and weaker rents reduce income.
  3. Property marketsLocal supply, demand and values vary by market and property type.
  4. Capital and developmentAcquisitions and developments need financing and may not earn what was planned.
  5. Regulation and taxesProperty, zoning and tax rules, including the rules for REIT status, affect results.

Source: 10-K, Item 1A Risk Factors (the company's own list, in the company's words)

Three years of key numbers

Every number links to its filing; hover for the XBRL tag. A dash means the number isn't cleanly available, and we don't estimate it.

US$FY2023FY2024FY2025
Revenue$4.5B$4.9B$5.8B
Net income−$30M$88M$262M
Operating cash flow$1.1B$1.3B$1.6B
Cash & equivalents (year end)$509M$898M$741M
Total debt (year end)$13.5B$13.5B$13.0B
Diluted shares406M416M463M
  • Revenue: Total revenue for the fiscal year, as the company reports it on its income statement.
  • Net income: Net income including the share that belongs to minority owners of subsidiaries.
  • Operating cash flow: Cash the business brought in from its day-to-day operations during the year (cash flow statement).
  • Cash & equivalents: Cash and short-term investments that count as cash equivalents on the balance sheet. Excludes longer-dated marketable securities.
  • Total debt: Commercial paper plus long-term debt, at carrying value.
  • Diluted shares: Weighted average shares outstanding for the year, including the effect of options and stock awards.

Learn more: How to read an income statement · Earnings per share, basic and diluted · Free cash flow · How to read a balance sheet · Growth rate calculator · P/E calculator · Market cap calculator · Free cash flow calculator · Return on equity and assets calculator

Explainers for this page

Plain-English guides to terms this file uses, with real numbers from filings.

About these numbers

  • Net income here includes the share that belongs to minority owners of subsidiaries, the figure the company's tagged data carries for the whole business.
  • The segment chart covers only part of revenue: the company reports other lines that aren't part of this breakdown.

Recent filings

FormFiledPeriod
10-QOct 28, 2026Sep 30, 2026
10-QJul 30, 2026Jun 30, 2026
10-QApr 28, 2026Mar 31, 2026
DEF 14AApr 1, 2026May 13, 2026
10-KFeb 6, 2026Dec 31, 2025

Learn more: 10-K vs. 10-Q vs. 8-K · Form 4 insider filings · Fiscal years and quarters

Common questions about Ventas

How does Ventas make money?

Ventas's revenue was $5.8B in fiscal 2025. By region in FY2025: United States (89%), Canada (9%) and United Kingdom (1%), as shares of total revenue. Total revenue was $5.8B. Source: 10-K for fiscal 2025, filed Feb 6, 2026.

What was Ventas's revenue in fiscal 2025?

$5.8B of revenue for the fiscal year ended Dec 31, 2025, up 18.5% from $4.9B in fiscal 2024. Fiscal 2023 was $4.5B. Source: 10-K for fiscal 2025, filed Feb 6, 2026.

Is Ventas profitable?

Ventas reported net income of $262M for fiscal 2025, up 196.0% from $88M in fiscal 2024. That is a profit under US accounting rules (GAAP). In the quarter ended Sep 30, 2026, net income was $67M. The page's About these numbers section explains what is included. Source: 10-K for fiscal 2025, filed Feb 6, 2026.

What did Ventas report in its latest quarterly filing?

Revenue was $1.8B in the quarter ended Sep 30, 2026, up 23.0% from $1.5B a year earlier. Net income was $67M, down 2.1% from $69M. Source: 10-Q for the quarter ended Sep 30, 2026, filed Oct 28, 2026.

What are the main risks Ventas faces?

Ventas's own risk factors are in Item 1A of its 10-K for fiscal 2025, filed Feb 6, 2026. Risks that are common among companies in the health care REITs industry include Interest rates; occupancy and rents; property markets; capital and development; regulation and taxes. The first: Higher rates raise borrowing costs and can lower property values. Source: 10-K, Item 1A Risk Factors.

Where do these Ventas numbers come from?

From Ventas's own SEC filings: the 10-K for fiscal 2025 (filed Feb 6, 2026) and the 10-Q for the quarter ended Sep 30, 2026 (filed Oct 28, 2026), read through the SEC's public XBRL data. Each number on this page links to its filing. Methodology explains how fiscal years and missing numbers are handled.

Tracked funds that report owning Ventas

From each fund’s latest Form 13F, which is filed up to 45 days after quarter end and lists long positions in US-listed stocks only. A listing here is a fact about a filing, not a view on the stock. What a 13F does and doesn’t show.

Disclosures

Editor holdings in VTR
The editor holds no position in Ventas (VTR). As of Nov 11, 2026.
Trading rule
The editor does not buy or sell VTR from 3 days before to 3 days after this page is published or substantively updated.
Compensation
Nobody paid for this page. No affiliate links on this page.
Sources
The company's SEC filings, linked next to each number or, for charts, in the source line under them.
Last updated
Nov 6, 2026

General education, the same for every reader. Not a recommendation to buy, sell or hold VTR, and it doesn't consider your situation.

Compare with peers

CompanyFiscal yearRevenueRevenue growthNet income
VentasVTRFY2025$5.8B+18.5%$262M
WelltowerWELLFY2025$10.8B+35.6%$962M
Healthpeak PropertiesDOCFY2025$2.8B+4.5%$71M
PrologisPLDFY2025$8.8B+7.2%$3.3B

Each row is that company’s latest fiscal year from its own 10-K, using its own revenue and net income lines. Fiscal years end in different months, and line definitions differ (banks, insurers and oil companies count revenue differently), so this is a rough side-by-side, not a like-for-like comparison.

More company files

New to filings? Learn has plain-English explainers and Tools has calculators. Methodology & Disclosures covers where every number comes from.